Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma". (January 2022) - Bateman, Eric D.; Khan, Asif H.; Xu, Yingxin; Guyot, Patricia; Chao, Jingdong; Kamat, Siddhesh; Rowe, Paul; Burnett, Heather; Msihid, Jerome; Weinreich, David; Pavord, Ian D.